Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,336 shares of the stock in a transaction dated Wednesday, April 5th. The shares were sold at an average price of $7.24, for a total transaction of $53,112.64. Following the completion of the transaction, the chairman now directly owns 1,885,755 shares in the company, […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,336 shares of the stock in a transaction on Wednesday, April 5th. The stock was sold at an average price of $7.24, for a total value of $53,112.64. Following the completion of the sale, the chairman now directly owns 1,885,755 shares in the company, […]
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,450,000 shares, an increase of 22.9% from the February 28th total of 1,180,000 shares. Based on an average daily volume of 119,800 shares, the days-to-cover ratio is presently 12.1 days. […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) had its price objective reduced by HC Wainwright from $48.00 to $45.00 in a research report released on Wednesday morning, The Fly reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Aadi Bioscience’s Q1 2023 earnings at ($0.61) EPS, Q2 2023 earnings […]